Skip to main content

Advertisement

SpringerLink
Log in

Dyspepsia and its overlap with irritable bowel syndrome

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Patients with functional dyspepsia and the irritable bowel syndrome are commonly seen in both primary care and gastroenterology subspecialty settings. Although functional dyspepsia and the irritable bowel syndrome can occur separately, recent research suggests that they often appear together as an overlap syndrome and thus may represent different portions of a unifying spectrum of disease. Despite their widespread prevalence, the pathogenesis of these disorders is not well established but may include impaired gastric emptying, gastric dysrhythmias, hypersensitivity (to acid exposure and to stretch), and Helicobacter pylori infection. Once other disorders in the differential diagnosis have been excluded, treatment of patients with functional dyspepsia, irritable bowel syndrome, and the overlap syndrome without alarm signs underscores current prevailing pathophysiologies and is generally empiric and symptom based. It is hoped that management of these disorders will become more targeted and efficacious as our understanding of them improves.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Henke CJ, Levin TR, Henning JM, et al.: Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000, 95:788–792

    Article  PubMed  CAS  Google Scholar 

  2. Kurata JH, Nogawa AN, Everhart JE: A prospective study of dyspepsia in primary care. Dig Dis Sci 2002, 47:797–803

    Article  PubMed  CAS  Google Scholar 

  3. Drossman DA, Corazziari E, Talley NJ, eds, et al: Rome II: The Functional Gastrointestinal Disorders, edn 2. McLean VA: Degnon Associates; 2000. This well-known book is a great resource to use as an initial overview of all the functional gastrointestinal diseases.

    Google Scholar 

  4. Dyspepsia: Managing Adults in Primary Care. London, UK: National Institute of Clinical Excellence; 2004.

  5. Talley NJ, Silverstein MD, Agreus L et al.: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998, 114:582–595.

    Article  PubMed  CAS  Google Scholar 

  6. The Danish Dyspepsia Group: Value of the unaided clinical diagnosis in dyspeptic patients in primary care. Am J Gastroenterol 2001, 96:1417–1421.

    Article  Google Scholar 

  7. Corazziari E: Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004, 18:613–631.

    Article  PubMed  Google Scholar 

  8. Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569–1580.

    Article  PubMed  CAS  Google Scholar 

  9. El-Serag HB, Talley NJ: Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004, 19:643–654.

    Article  PubMed  CAS  Google Scholar 

  10. Talley NJ, Zinsmeister AR, Schleck CD, et al.: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992, 102:1259–1268.

    PubMed  CAS  Google Scholar 

  11. Majumdar SR, Soumerai SB, Farraye FA, et al.: Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol 2003, 98:2409–2414.

    Article  PubMed  Google Scholar 

  12. Koloski NA, Talley NJ, Boyce PM: Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors. Am J Gastroenterol 2001, 96:1340–1349.

    Article  PubMed  CAS  Google Scholar 

  13. Koloski NA, Talley NJ, Huskic SS, et al.: Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003, 17:841–851.

    Article  PubMed  CAS  Google Scholar 

  14. Howell S, Talley NJ: Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol 1999, 11:881–886.

    Article  PubMed  CAS  Google Scholar 

  15. Agreus L, Svardsudd K, Nyren O, et al.: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995, 109:671–680.

    Article  PubMed  CAS  Google Scholar 

  16. Locke GR III, Zinsmeister AR, Fett SL, et al.: Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil 2005, 17:29–34.

    Article  PubMed  Google Scholar 

  17. Corsetti M, Caenepeel P, Fischler B, et al.: Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia. Am J Gastroenterol 2004, 99:1152–1159. This detailed study is among the first to compare symptomatic and pathophysiologic differences between the overlap syndrome and FD.

    Article  PubMed  Google Scholar 

  18. Olafsdottir LB, Gudjonsson H, Thjodleifsson B, et al.: Epidemiological study of functional bowel disorders in Iceland. Laeknabladid 2005, 91:329–333.

    PubMed  Google Scholar 

  19. Minocha A, Chad W, Do W, et al.: Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among African Americans compared to Caucasians: a population-based study. Dig Dis Sci 2006, 51:218–226.

    Article  PubMed  Google Scholar 

  20. Quartero AO, de Wit NJ, Lodder AC, et al.: Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998, 43:2028–2033.

    Article  PubMed  CAS  Google Scholar 

  21. Stanghellini V, Tosetti C, Barbara G, et al.: Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome. Am J Gastroenterol 2002, 97:2738–2743.

    Article  PubMed  Google Scholar 

  22. Koch KL, Sung-Pyo H, Xu L: Reproducibility of gastric myoelectrical activity and the water load test in patients with dysmotility-like dyspepsia symptoms and in control subjects. J Clin Gastroenterol 2000, 31:125–129. This trial supports the hypothesis that gastric dysrhythmias are important to consider in the pathophysiology of patients with FD, especially those with dysmotility-like dyspepsia.

    Article  PubMed  CAS  Google Scholar 

  23. Muth ER, Koch KL, Stern RM: Significance of autonomic nervous system activity in functional dyspepsia. Dig Dis Sci 2000, 45:854–863.

    Article  PubMed  CAS  Google Scholar 

  24. Trimble KC, Farouk R, Pryde A, et al.: Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci 1995, 40:1607–1613.

    Article  PubMed  CAS  Google Scholar 

  25. Costantini M, Sturniolo GC, Zaninotto G, et al.: Altered esophageal pain threshold in irritable bowel syndrome. Dig Dis Sci 1993, 38:206–212.

    Article  PubMed  CAS  Google Scholar 

  26. Holtmann G, Goebell H, Talley NJ: Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997, 92:954–959.

    PubMed  CAS  Google Scholar 

  27. Bouin M, Lupien F, Riberdy M, et al.: Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation? Neurogastroenterol Motil 2004, 16:311–314.

    Article  PubMed  CAS  Google Scholar 

  28. Samsom M, Verhagen MA, van Berge Henegouwen GP, et al.: Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999, 116:515–520.

    Article  PubMed  CAS  Google Scholar 

  29. Lee KJ, Vos R, Janssens J, et al.: Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004, 286:G278-G284.

    Article  PubMed  CAS  Google Scholar 

  30. Mearin F, Perez-Oliveras M, Perello A, et al.: Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005, 129:98–104.

    Article  PubMed  Google Scholar 

  31. Moayyedi P, Forman D, Braunholtz D, et al.: The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol 2000, 95:1448–1455.

    Article  PubMed  CAS  Google Scholar 

  32. Talley NJ, Weaver A, Zinsmeister A, et al.: Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992, 136:165–177.

    PubMed  CAS  Google Scholar 

  33. Papatheodoridis GV, Karamanolis DG: Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population. Scand J Gastroenterol 2005, 40:412–421.

    PubMed  CAS  Google Scholar 

  34. Laine L, Schoenfeld P, Fennerty MB: Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 134:361–369.

    PubMed  CAS  Google Scholar 

  35. Moayyedi P, Deeks J, Talley NJ, et al.: An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol 2003, 98:2621–2626. This large meta-analysis was among the first studies to suggest that clearance of H. pylori infection might help the symptoms of FD. Numerous previous studies suggested that clearance of H. pylori organisms did not positively affect the symptoms of FD.

    Article  PubMed  Google Scholar 

  36. Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the BOND and OPERA studies). Aliment Pharmacol Ther 1998, 12:1055–1065.

    Article  PubMed  CAS  Google Scholar 

  37. Peura DA, Kovacs TO, Metz DC, et al.: Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med 2004, 116:740–748.

    Article  PubMed  CAS  Google Scholar 

  38. Talley NJ, Vakil NB, Moayyedi P: American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005, 129:1756–1780. Excellent and detailed overview of the diagnosis, evaluation, and management of patients with dyspepsia.

    Article  PubMed  Google Scholar 

  39. Bekhti A, Rutgeerts L: Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979, 55(Suppl 1):30–32.

    PubMed  Google Scholar 

  40. Holtmann G, Talley NJ, Liebregts T, et al.: A placebocontrolled trial of itopride in functional dyspepsia. N Engl J Med 2006, 354:832–840.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Gastroenterology, Department of Internal Medicine, Wake Forest University School of Medicine, 27157, Winston-Salem, NC, USA

    Kenneth L. Koch MD

Authors
  1. William M. Outlaw MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth L. Koch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth L. Koch MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Outlaw, W.M., Koch, K.L. Dyspepsia and its overlap with irritable bowel syndrome. Curr Gastroenterol Rep 8, 266–272 (2006). https://doi.org/10.1007/s11894-006-0046-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-006-0046-0

Keywords

Search

Navigation